BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30361377)

  • 1. Detection at Public Facilities of
    Bikas A; Wu D; Bethancourt E; Orquiza M; Bloom G; Burman KD; Wartofsky L; Van Nostrand D
    J Nucl Med; 2019 May; 60(5):638-643. PubMed ID: 30361377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selected Radiation Safety Aspects Including Transportation and Lodging After Outpatient
    Gomes-Lima CJ; Wu D; Kharazi PH; Khojekar GJ; Ringel MD; Vetter RJ; Bloom G; Burman KD; Wartofsky L; Van Nostrand D
    Thyroid; 2017 Dec; 27(12):1558-1565. PubMed ID: 29132255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After
    Wu D; Gomes Lima CJ; Bloom G; Burman KD; Wartofsky L; Van Nostrand D
    J Nucl Med; 2020 Mar; 61(3):397-404. PubMed ID: 31451488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of total hip prostheses at airport security checkpoints: how has heightened security affected patients?
    Johnson AJ; Naziri Q; Hooper HA; Mont MA
    J Bone Joint Surg Am; 2012 Apr; 94(7):e44. PubMed ID: 22488628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current safety practices relating to I-131 administration for diseases of the thyroid: a survey of physicians and allied practitioners.
    Greenlee C; Burmeister LA; Butler RS; Edinboro CH; Morrison SM; Milas M;
    Thyroid; 2011 Feb; 21(2):151-60. PubMed ID: 21275765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer: Study of External Dose Rate Attenuation Law and Individualized Patient Management.
    Li P; Zhang A; Liu Y; Xu C; Tang L; Yuan H; Liu Q; Wang X; Feng D; Wang L; Huang G; Song S
    Thyroid; 2019 Jan; 29(1):93-100. PubMed ID: 30351248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioactive iodine therapy for malignant and benign thyroid disease: a Canadian national survey of physician practice.
    Demeter S; Leslie WD; Levin DP
    Nucl Med Commun; 2005 Jul; 26(7):613-21. PubMed ID: 15942482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of total hip arthroplasties at airport security checkpoints - how do updated security measures affect patients?
    Issa K; Pierce TP; Gwam C; Festa A; Scillia AJ; Mont MA
    Hip Int; 2018 Mar; 28(2):122-124. PubMed ID: 28885644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.
    Lang BH; Wong IO; Wong KP; Cowling BJ; Wan KY
    Surgery; 2012 Jun; 151(6):844-50. PubMed ID: 22341041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of pregnancy after radioactive iodine treatment for well differentiated thyroid carcinomas.
    Lin JD; Wang HS; Weng HF; Kao PF
    J Endocrinol Invest; 1998 Nov; 21(10):662-7. PubMed ID: 9854681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giving radioiodine? Think about airport security alarms.
    Kaniuka-Jakubowska S; Lewczuk A; Mizan-Gross K; Obołończyk L; Lass P; Sworczak K
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):148-50. PubMed ID: 22226338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
    Lin JD; Kao PF; Chao TC
    Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation alarm at an airport after radioiodine therapy.
    Sinzinger H; Aiginger P; Neumann I; Havlik E
    Nucl Med Commun; 2005 Jan; 26(1):67-8. PubMed ID: 15604950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment.
    Dewji S; Bellamy M; Hertel N; Leggett R; Sherbini S; Saba M; Eckerman K
    Med Phys; 2015 Apr; 42(4):1851-7. PubMed ID: 25832075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma.
    Koong SS; Reynolds JC; Movius EG; Keenan AM; Ain KB; Lakshmanan MC; Robbins J
    J Clin Endocrinol Metab; 1999 Mar; 84(3):912-6. PubMed ID: 10084570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of radioactive iodine in the treatment of well-differentiated thyroid cancer.
    Weigel RJ; McDougall IR
    Surg Oncol Clin N Am; 2006 Jul; 15(3):625-38. PubMed ID: 16882501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.
    Sacks W; Wong RM; Bresee C; Braunstein GD
    Thyroid; 2015 Apr; 25(4):377-85. PubMed ID: 25578116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study.
    Ceccarelli C; Bencivelli W; Morciano D; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3512-5. PubMed ID: 11502772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation.
    Lin JD; Chao TC; Huang MJ; Weng HF; Tzen KY
    Am J Clin Oncol; 1998 Feb; 21(1):77-81. PubMed ID: 9499265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma.
    Verburg FA
    Q J Nucl Med Mol Imaging; 2019 Sep; 63(3):253-257. PubMed ID: 31271272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.